Long‐term outcomes following transplantation of tumourectomised kidneys: a 30‐year experience
Objectives To report the long‐term oncological and graft outcomes of a 30‐year single‐centre experience with transplantation of carefully selected tumourectomised kidneys. Patients and Methods A retrospective single‐centre cohort study was performed of all recipients who underwent kidney transplantation following ex vivo bench excision of electively or incidentally detected kidney tumours ≤3 cm between 1996 and 2026 at the Princess Alexandra Hospital (Brisbane, Australia). Recipient, donor, and tumour characteristics, perioperative outcomes, oncological outcomes, patient survival and graft survival were evaluated. Results A total of 64 recipients underwent kidney transplantation following ex vivo bench excision of a small kidney mass during the study period, with a median (interquartile range [IQR]) follow‐up of 11.3 (6.9–15.8) years. The median (IQR) recipient age was 62.5 (54.7–68.6) years. Most donor tumours were small, organ‐confined renal cell carcinomas (RCC) with negative surgical margins following bench excision. Three presumed tumour recurrences occurred during follow‐up (5.0%), comprising one local recurrence at the previous tumour excision site and two presumed de novo allograft tumours, with no metastatic disease or cancer‐specific mortality. At latest follow‐up, 50 recipients had died, including 34 (68.0%) with a functioning graft. Estimated patient survival was 93.5%, 88.7% and 62.9% at 1, 5 and 10 years respectively, with acceptable long‐term graft outcomes. Conclusions Transplantation of carefully selected tumourectomised kidneys provides long‐term oncological safety and acceptable patient and graft outcomes. These findings support the continued consideration of tumourectomised kidneys from living and deceased donors as a safe and effective strategy to expand the donor pool, reduce organ discard and increase access to kidney transplantation.
Authors
- Handoo Rhee (ORCID: https://orcid.org/0000-0002-1722-7127)
- Ai Lin Tan
- David Wayne Johnson (ORCID: https://orcid.org/0000-0001-5491-3460)
- Ryan Gately (ORCID: https://orcid.org/0000-0002-1951-9836)
- Nicole M. Isbel (ORCID: https://orcid.org/0000-0002-9566-7179)
- Scott B. Campbell (ORCID: https://orcid.org/0000-0003-1338-2151)
- John Preston
- David L. Nicol (ORCID: https://orcid.org/0000-0002-5623-7467)
- Anthony Griffin
- Rachel Cockburn (ORCID: https://orcid.org/0009-0001-0790-5107)
- Simon Wood
- Malcolm Lawson
- Michael Keys (ORCID: https://orcid.org/0009-0002-5881-2637)
- Vijay Kanagarjah
Institutions
- Translational Research Institute (AU)
- Royal Marsden NHS Foundation Trust (GB)
- The University of Queensland (AU)
- Princess Alexandra Hospital (AU)
- Metro South Health (AU)
- Royal Marsden Hospital (GB)
Publication Details
- Journal
- British Journal of Urology
- Published
- 2026-11-19
- DOI
- https://doi.org/10.1111/bju.70555
- Primary Topic
- Renal Transplantation Outcomes and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00